Next Generation CAR & T Cell Therapies 2021 Agendakeyboard_arrow_right
Search & Filter
keyboard_arrow_right
keyboard_arrow_left
Hide
Next Generation CAR & T Cell Therapies 2021 Agenda
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Next Generation CAR & T Cell Therapies 2021 Agenda
search
Streams
Formats
Next Generation CAR & T Cell Therapies 2021 Agenda9:45am-9:50am5
mins
CONFERENCE DAY ONE - June 22nd
Opening Remarks from Sarah Lintern, Conference Director
Next Generation CAR & T Cell Therapies 2021 Agenda9:50am-10:00am10
mins
CONFERENCE DAY ONE - June 22nd
Conference Opening and Welcome
Next Generation CAR & T Cell Therapies 2021 Agenda9:50am-10:00am10
mins
CONFERENCE DAY TWO - June 23rd
Conference Opening and Welcome
Next Generation CAR & T Cell Therapies 2021 Agenda9:50am-10:00am10
mins
CONFERENCE THREE - June 24th
Conference Opening and Welcome
Next Generation CAR & T Cell Therapies 2021 Agenda10:05am-10:25am20
mins
CONFERENCE DAY ONE - June 22nd
临床型汽车T发现候选人选择,如CD70或DLL3
- Siler Panowski-Director of Biology, Solid Tumors,Allogene (pending final confirmation)
Next Generation CAR & T Cell Therapies 2021 Agenda10:05am-10:25am20
mins
CONFERENCE DAY TWO - June 23rd
Harnessing of Blood Derived Gamma Delta T Cells for Cancer Immunotherapy
- 约翰马赫-CSO, Leucid Bio,Clinical Senior Lecturer in Immunology, Kings College London
Next Generation CAR & T Cell Therapies 2021 Agenda10:05am-10:25am20
mins
CONFERENCE THREE - June 24th
Translational Lessons from Pivotal Axi-Cel Trial (ZUMA-1): Implications for Safety, Efficacy and Next Generation Products
- Simone Filosto-Principal Scientist I, Cell Biology,Kite Pharma
Next Generation CAR & T Cell Therapies 2021 Agenda10:30am-10:50am20
mins
CONFERENCE DAY ONE - June 22nd
Creating a Feedback Loop Between Clinical Trials and Translational Science for Product Improvement
Next Generation CAR & T Cell Therapies 2021 Agenda10:30am-10:50am20
mins
CONFERENCE DAY TWO - June 23rd
Clinical Development with Two Distinct Proprietary and Unique Non-Gene Edited Allogeneic Technology Approaches
- Frédéric F. Lehmann-Head Global Clinical Development and Medical Affairs, Vice President,Celyad, Belgium
Next Generation CAR & T Cell Therapies 2021 Agenda10:30am-10:50am20
mins
CONFERENCE THREE - June 24th
Contextual Secretion of Nanoscale, Antigen-Dependent IL-12 By CAR T Cells for Cancer Treatment
- Zhifen Yang-Associate Director,Refuge Biotech
Next Generation CAR & T Cell Therapies 2021 Agenda10:55am-11:15am20
mins
CONFERENCE DAY ONE - June 22nd
Spotlight Presentation
Next Generation CAR & T Cell Therapies 2021 Agenda10:55am-11:15am20
mins
CONFERENCE DAY TWO - June 23rd
PANEL: Next Generation CAR Strategies – Allo, NK and Macrophages for Treating Multiple Patients
- John Tomtishen-Director of Manufacturing, Technical Operations,Legend Biotech Co., USA
- 约翰马赫-CSO, Leucid Bio,Clinical Senior Lecturer in Immunology, Kings College London
- Frédéric F. Lehmann-Head Global Clinical Development and Medical Affairs, Vice President,Celyad, Belgium
Next Generation CAR & T Cell Therapies 2021 Agenda10:55am-11:15am20
mins
CONFERENCE THREE - June 24th
Spotlight Presentation
Next Generation CAR & T Cell Therapies 2021 Agenda11:15am-11:35am20
mins
CONFERENCE DAY ONE - June 22nd
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda11:15am-11:35am20
mins
CONFERENCE DAY TWO - June 23rd
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda11:15am-11:35am20
mins
CONFERENCE THREE - June 24th
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda11:35am-12:00pm25
mins
CONFERENCE DAY ONE - June 22nd
Morning Coffee and Networking
Next Generation CAR & T Cell Therapies 2021 Agenda11:35am-12:00pm25
mins
CONFERENCE DAY TWO - June 23rd
Morning Coffee and Networking
Next Generation CAR & T Cell Therapies 2021 Agenda11:35am-12:00pm25
mins
CONFERENCE THREE - June 24th
Morning Coffee and Networking
Next Generation CAR & T Cell Therapies 2021 Agenda12:00pm-12:20pm20
mins
CONFERENCE DAY ONE - June 22nd
In vivo engineering of CAR-T cells: A promising new approach to cancer immunotherapy
- Shon Green-翻译科学高级总监,Umoja Biopharma
Next Generation CAR & T Cell Therapies 2021 Agenda12:00pm-12:20pm20
mins
CONFERENCE DAY TWO - June 23rd
Driving lupus out with CARs
- 马克·拉迪奇-Associate Professor, Microbiology, Immunology and Biochemistry,University of Tennessee Health Science Center
Next Generation CAR & T Cell Therapies 2021 Agenda12:00pm-12:20pm20
mins
CONFERENCE THREE - June 24th
Fusion Proteins to Bridge CAR19 T Cell and Tumor Cells
- Paul Rennert-President & CSO,Aleta BioTherapeutics
Next Generation CAR & T Cell Therapies 2021 Agenda12:25pm-12:45pm20
mins
CONFERENCE DAY ONE - June 22nd
CAR-T therapy for solid tumors: The Road Ahead
- Shipra Das-Team Leader Immuno-Oncology,Cellectis
Next Generation CAR & T Cell Therapies 2021 Agenda12:25pm-12:45pm20
mins
CONFERENCE DAY TWO - June 23rd
Clinical Case Study – Novel CARs & TCRs
- Paul Lammers-President & CEO,Triumvira Immunologics
Next Generation CAR & T Cell Therapies 2021 Agenda12:25pm-12:45pm20
mins
CONFERENCE THREE - June 24th
DAP10/12 co-stimulation/Signaling Domains & HuLym-1 CAR T-cells Targeting HLA-DR Expressed by Lymphomas and Most Solid Tumors
- Alan Epstein-Professor of Pathology,Keck School of Medicine of USC, USA
Next Generation CAR & T Cell Therapies 2021 Agenda12:50pm-1:10pm20
mins
CONFERENCE DAY ONE - June 22nd
Targeted CART Approaches for Solid Tumours
- Astero Klampatsa-Team Leader,Institute of Cancer Research
Next Generation CAR & T Cell Therapies 2021 Agenda12:50pm-1:10pm20
mins
CONFERENCE DAY TWO - June 23rd
Spotlight Presentation
Next Generation CAR & T Cell Therapies 2021 Agenda12:50pm-1:10pm20
mins
CONFERENCE THREE - June 24th
Spotlight Presentation
Next Generation CAR & T Cell Therapies 2021 Agenda1:10pm-1:30pm20
mins
CONFERENCE DAY ONE - June 22nd
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda1:10pm-1:30pm20
mins
CONFERENCE DAY TWO - June 23rd
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda1:10pm-1:30pm20
mins
CONFERENCE THREE - June 24th
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda1:30pm-2:15pm45
mins
CONFERENCE DAY ONE - June 22nd
Sponsored Luncheon Presentations
Next Generation CAR & T Cell Therapies 2021 Agenda1:30pm-2:15pm45
mins
CONFERENCE DAY TWO - June 23rd
Sponsored Luncheon Presentations
Next Generation CAR & T Cell Therapies 2021 Agenda1:30pm-2:15pm45
mins
CONFERENCE THREE - June 24th
Sponsored Luncheon Presentations
Next Generation CAR & T Cell Therapies 2021 Agenda2:15pm-2:35pm20
mins
CONFERENCE DAY ONE - June 22nd
Switchable CAR-T for Solid Tumours
- Travis Young-VP, Biologics,Calibr at Scripps Research, USA
Next Generation CAR & T Cell Therapies 2021 Agenda2:15pm-2:35pm20
mins
CONFERENCE DAY TWO - June 23rd
CAR Macrophage Case Study
- Michael Klichinsky-Co-Founder,Carisma Therapeutics
Next Generation CAR & T Cell Therapies 2021 Agenda2:15pm-2:35pm20
mins
CONFERENCE THREE - June 24th
Centralized vs. Decentralized Patient Treatment Approaches
- Allison Matthews-Senior Service Designer, Innovation and Design,Mayo Clinic
Next Generation CAR & T Cell Therapies 2021 Agenda2:40pm-3:00pm20
mins
CONFERENCE DAY ONE - June 22nd
Solid Tumour Targeted CAR’s with Armor Tailored for Solid Tumour Microenvironments
- Blake Aftab-Vice President, Preclinical & Translational Science,Atara Biotherapeutics
Next Generation CAR & T Cell Therapies 2021 Agenda2:40pm-3:00pm20
mins
CONFERENCE DAY TWO - June 23rd
Predictive Biomarkers of Response and Toxicity to Anti-CD19 CAR T Cell Therapy
- 约翰罗西-Director, Translational Medicine,Kite, a Gilead Company, USA
Next Generation CAR & T Cell Therapies 2021 Agenda2:40pm-3:00pm20
mins
CONFERENCE THREE - June 24th
Progress in Manufacturing of Lentiviral Vectors in Suspension Systems
- David Hsu-Senior Director,City of Hope
Next Generation CAR & T Cell Therapies 2021 Agenda3:00pm-3:20pm20
mins
CONFERENCE THREE - June 24th
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda3:05pm-3:25pm20
mins
CONFERENCE DAY ONE - June 22nd
3T Case Study - Identification of Novel Targets for the Treatment of Solid Tumours in Broad Patient Populations
- Hanspeter Gerber-CSO & SVP,3T Biosciences
Next Generation CAR & T Cell Therapies 2021 Agenda3:05pm-3:25pm20
mins
CONFERENCE DAY TWO - June 23rd
CRISPR Screens for Finding New or Selecting T Cell Edits for Different Solid Tumours
- Birgit肖特-Vice President, Immunology (Cell Therapies),Intellia Therapeutics, USA
Next Generation CAR & T Cell Therapies 2021 Agenda3:20pm-3:25pm5
mins
CONFERENCE THREE - June 24th
End of Day Three
Next Generation CAR & T Cell Therapies 2021 Agenda3:30pm-3:50pm20
mins
CONFERENCE DAY ONE - June 22nd
TCR Identification in Solid Tumour Indications
- Felix Lorenz-Head of Captain T Cell,Max-Delbrück-Center for Molecular Medicine (MDC Berlin), Germany
Next Generation CAR & T Cell Therapies 2021 Agenda3:30pm-3:50pm20
mins
CONFERENCE DAY TWO - June 23rd
Spotlight Presentation
Next Generation CAR & T Cell Therapies 2021 Agenda3:50pm-4:10pm20
mins
CONFERENCE DAY ONE - June 22nd
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda3:50pm-4:10pm20
mins
CONFERENCE DAY TWO - June 23rd
Speaker Q&A
Next Generation CAR & T Cell Therapies 2021 Agenda4:10pm-4:15pm5
mins
CONFERENCE DAY ONE - June 22nd
End of Day One
Next Generation CAR & T Cell Therapies 2021 Agenda4:10pm-4:15pm5
mins
CONFERENCE DAY TWO - June 23rd
End of Day Two
Filter
Streams
Formats